Abiopharma

SStartrade Tech, Inc. is a US company that is focused on utilizing its strong capital position, extensive industry contacts and expertise to identify, evaluate and invest in quality gold mining assets that have the capacity to generate significant returns and growth for the Company and its shareholders while limiting downside risk. The Company holds a 74 percent interest in the voting shares of the Swiss corporation, SStarTrade SA, which aims to develop million ounce gold deposits in the Russian Federation, one of the most gold rich asset areas in the world. As of April 25th, the company has suspended all activities in Russia except those to grant maintenance of assets owned. Business developments are being studied to bring knowledge and expertise to other markets based on experience gathered with russian operations. The compan is now turning the knowledge to trading ventures and consultancy work working with parteners in the Far and Middle East countries.

Additional info from OTC:
SStartrade Tech, Inc. is a US company that is focused on utilizing its strong capital position, extensive industry contacts and expertise to identify, evaluate and invest in quality gold mining assets that have the capacity to generate significant returns and growth for the Company and its shareholders while limiting downside risk. The Company holds a 74 percent interest in the voting shares of the Swiss corporation, SStarTrade SA, which aims to develop million ounce gold deposits in the Russian Federation, one of the most gold rich asset areas in the world. As of April 25th, the company has suspended all activities in Russia except those to grant maintenance of assets owned. Business developments are being studied to bring knowledge and expertise to other markets based on experience gathered with russian operations. The compan is now turning the knowledge to trading ventures and consultancy work working with parteners in the Far and Middle East countries.